Defensive Franchises: Staples, Pharma & Insurers

Tech is selling off even after TSMC's record quarter, so money may rotate toward cash-generative defensive franchises that sit at or near 52-week highs. Eli Lilly's $1 trillion milestone keeps big healthcare in focus. The basket pairs large-cap pharma and a managed-care name with staples makers whose demand doesn't depend on AI multiples. Catalysts: - 2026-10-15 GLP-1s take Eli Lilly to a $1 trillion market cap (https://www.forbes.com/sites/amyfeldman/2026/10/15/glp-1s-took-eli-lilly-to-1-trillion-ceo-dave-ricks-is-betting-billions-he-can-do-it-again/) Launch basket (equal weight): ABBV, AMGN, MRK, LLY, UNH, KO, PG Rules: 1. No inverse, leveraged or volatility ETFs. 2. Only names tradable at the enrolled brokers (Moomoo): no OTC listings, no dead tickers, nothing on the refused list.